Prokidney (PROK) FCF Margin (2024 - 2026)

Prokidney (PROK) reported FCF Margin of 20119.03% for Q1 2026, down 675946.0% year-over-year from N/an in Q1 2025, and down 18.3% on a QoQ basis from 17006.67% in Q4 2025.

Prokidney (PROK) has 3 years of FCF Margin data on file, last reported at 20119.03% in Q1 2026.

  • Quarterly FCF Margin fell 675946.0% year-over-year to 20119.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16879.08% (up 3246112.0% YoY) and the FY2025 annual result came in at 15152.63%, up 18992632.0% from the prior year.
  • FCF Margin declined to 20119.03% in Q1 2026 per PROK's latest filing, from 17006.67% in the prior quarter.
  • Across five years, FCF Margin topped out at 13359.57% in Q1 2025 and bottomed at 65368.42% in Q4 2024.
  • The 3-year median for FCF Margin is 16315.1% (2025), against an average of 24354.73%.
  • The widest annual swing landed in 2025, when FCF Margin soared 4836175 bps; it then tumbled 675946 bps in 2026.
  • Tracing PROK's FCF Margin over 3 years: stood at 65368.42% in 2024, then soared by 74 bps to 17006.67% in 2025, then decreased by 18 bps to 20119.03% in 2026.
  • Per Business Quant, the three latest PROK FCF Margin figures stand at 20119.03% (Q1 2026), 17006.67% (Q4 2025), and 14651.15% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 Prokidney 259.72 Mn 1.55 Bn - -20,119.03%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20,119.03%
Dec 31, 2025 -17,006.67%
Sep 30, 2025 -14,651.15%
Jun 30, 2025 -15,623.53%
Mar 31, 2025 -13,359.57%
Dec 31, 2024 -65,368.42%